Journal of Endocrinological Investigation

, Volume 14, Issue 8, pp 701–717 | Cite as

Thyroid consequences of Chernobyl accident in the countries of the European Community

  • J. Malone
  • J. Unger
  • F. Delange
  • R. Lagasse
  • J. E. Dumont
Review Article


Radioiodine thyroid cancer nuclear accident risk 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nuclear Regularly Commission Three Mile Island A report to the commissionners and the public. NUREG/CR-1250 (Washington, USNRC) 1980.Google Scholar
  2. 2.
    Presidents Commission Report of the Presidents Commission on the Accident at Three Mile Island, the need for change: the legacy of TMI (Washington, US Gvt, Printing Office) 1979.Google Scholar
  3. 3.
    IAEA. International Atomic Energy Agency. Summary Report on the Post-accident Review Meeting on the Chernobyl Accident. Safety series no 75-INSAG-1 (Vienna: International Atomic Energy Agency) 1986.Google Scholar
  4. 4.
    Clarke R.H. Reactor accidents in perspective. Br. J. Radiol. 60: 1182, 1987.PubMedCrossRefGoogle Scholar
  5. 5.
    Evans J.S., Moeller D.W., Cooper D.W. Health effect model for nuclear power plant accident consequence analysis (Washington, Supt. of Documents; Springfield, Nat. Tech. Information Service. Nureg/CR-4124, S and 85–7185, 1985.Google Scholar
  6. 6.
    Dumont J.E., Malone J.F. Radiation induced damage. In: Irradiation and thyroid disease: dosimetric, clinical and carcinogenic aspects (Brussels, CEC, EUR 6713 EN) 1980, pp 140.Google Scholar
  7. 7.
    Degroot L.J., Fhohman L.A., Kaplan E.L., Refetoff S. Radiation-associated thyroid carcinoma. Grune and Stratton, New York, 1977.Google Scholar
  8. 8.
    ICRP. Recommendations of the National Commission on Radiological Protection. ICRP Publication n∘ 26. Annals of the ICRP 1(3) 1977.Google Scholar
  9. 9.
    Malone J.F. Thyroid irradiation and the new ICRO dose limits. Br. J. radiol. 51: 553, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Segre E. Nuclei and Particles. W.A. Benjamin New York, 1965, p. 491.Google Scholar
  11. 11.
    Salo A. Radionuclide levels in Europe after Chernobyl. Presented at European Thyroid Association Special Symposium on Radiation and the Thyroid. Lausanne, July 1987.Google Scholar
  12. 12.
    Fry F.A. The Chernobyl reactor accident: The impact on the United Kingdom. Br. J. Radiol. 60: 1147, 1987.PubMedCrossRefGoogle Scholar
  13. 13.
    Beardsley T. US Analysis. Nature 321: 187, 1986.Google Scholar
  14. 14.
    Smith F.B. Chernobyl. The radioactive plume and its consequences. Presented at the 16th International Meeting on Air Pollution Modelling and its Applications, 6th–10th April 1987, Lindau, FRG.Google Scholar
  15. 15.
    IPSM. Institute of Physical Sciences in Medicine. Chernobyl: Response of medical physics Departments in the United Kingdom. Ed. by J.K. Haywood London, York, Institute of Physical Sciences in Medicine, Report No 50, 1986.Google Scholar
  16. 16.
    NEA. The Radiological Impact of the Chernobyl Accident in OECD countries. Paris, Nuclear Energy Agency/Organization for Economic Cooperation and development, 1987.Google Scholar
  17. 17.
    Simon A.P. H.M., Wilson J. Tracing the Cloud from Chernobyl. New Scientist 111: 42, 1986.Google Scholar
  18. 18.
    Smith F.B., Clark, M.J. Radionuclide deposition from the Chernobyl cloud. Nature 322: 690, 1986.PubMedCrossRefGoogle Scholar
  19. 19.
    NRPB. A preliminary assessment of the radiological impact of the Chernobyl reactor accident on the population of the European Community (Brussels, CEC) 1986.Google Scholar
  20. 20.
    Malone J.F. Recent developments in dosimetry of radionuclides in the thyroid. In: Dumont J.E., Malone J., Van Herle A.J. (Eds) 40–109, 1980.Google Scholar
  21. 21.
    UNSCEAR United Nations Scientific Committee on the Effects of Atomic Radiation. Ionizing radiation: Source and biological effects (United Nations, New York) (1977, 1982, 1989).Google Scholar
  22. 22.
    Assimakopoulos P.A., Ioannides K.G., Pakou A.A. The environmental behaviour of 131I in Northwestern Greece following the nuclear reactor accident at Chernobyl. Health Phys. 55: 783, 1988.PubMedCrossRefGoogle Scholar
  23. 23.
    Castronovo, F.P. Iodine I131 thyroid uptake results in travelers returning from Europe after the Chernobyl accident. J. Nucl. Med. 28: 535, 1987.PubMedGoogle Scholar
  24. 24.
    Loevinger R., Budinger T.F., Watson E.E. MIRD primer New York, Society of Nuclear Medicine, 1988.Google Scholar
  25. 25.
    Malone J.F., Gilligan P. Problems in Dosimetry of Special Groups: In Utero, the Neonate, Children and Adults. In “Proceedings of WHO Workshop of Iodine Prophylaxis” in press (WHO, Copenhagen), 1989.Google Scholar
  26. 26.
    Gutekunst R., Smolarek K.H., Hasenpusch U., Stubbe P., Friedrich H.J., Wood W.G., Scriba P.C. Goitre epidemiology: thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol (Copenh) 112: 494, 1989.Google Scholar
  27. 27.
    Dumont J.E., Malone J.F., Van Herle A.J. Irradiation and thyroid diseases: dosimetric, clinical and carcinogenic aspects. (Brussels, CEC, EUR 6713EN) 1980.Google Scholar
  28. 28.
    Malone J.F., Cullen M.J. Hypothyroidism after131I therapy. Lancet 2: 73, 1975.Google Scholar
  29. 29.
    Upton A.C. Biological basis for radiological protection and its application to risk assessment: Cancer induction and non-stochastic effects. Br. J. Radiol. 60: 1, 1987.PubMedCrossRefGoogle Scholar
  30. 30.
    Larsen P.R., Conrad R., Krudson K., Robins J., Wolff J., Rall J.E., Nicolof J.T., Dobyns B.M. Thyroid hypofunction after exposure to fallout from a hydrogen bomb. J. Am. Med. Ass. 247: 1571, 1982.CrossRefGoogle Scholar
  31. 31.
    BEIR. Biological effects of iodinizing radiation. The effects on population of exposure to low levels of ionizing radiation. Natl. Acad. Sci. Washington, 1980.Google Scholar
  32. 32.
    Maxon H., Thomas S., Buncher C. Thyroid effects. Appendix A in Evans et al. 11–181 to 11–221, 1985.Google Scholar
  33. 33.
    Rotblat J. A tale of two cities. New Scientist, January 46–50, 1988.Google Scholar
  34. 34.
    Malone J., O’Connor M.K., Hendou J.H. The cellular disease of radiation effects in thyroid, salivary and adrenal epithelia. In: Potten C.S., Hendou J.H. (Eds.) Thyrotoxic in solid tissue, effects on cell lineage. Churchill Livingstone 1983, p. 186.Google Scholar
  35. 35.
    Holm L.E. Incidence of malignant thyroid tumors in man after diagnostic and therapeutic doses of iodine-131 (Stockholm M.D. Thesis) 1980.Google Scholar
  36. 36.
    Holm L.E., Eklund G., Lundell G. Incidence of malignant thyroid tumors after exposure to diagnostic doses of iodine-131. J. Natl. Cancer Inst. 65: 1221, 1981.Google Scholar
  37. 37.
    Holm L.E., Wiklund K.E., Lundell G.E., Bergman N.A., Bjelkengren G., Lederquist E.S., Ericsson U.C., Larsson L.G., Lindberg M.E., Lindberg R.S., Wirklund H.V., Boice J.D. Thyropid cancer after diagnostic doses of iodine-131: a retrospective cohort study. J. Natl. Cancer. Inst. 80: 1132, 1988.PubMedCrossRefGoogle Scholar
  38. 38.
    Anspaugh L.R., Catlin R.J., Goldman M. The global impact of the Chernobyl reactor accident. Sci. 242: 1513, 1988.CrossRefGoogle Scholar
  39. 39.
    Waine E.J., Koutras D.A., Alexander W.D. Clinical aspects of iodine metabolism. Blackwell Publ., Oxford, 1964, p. 1.Google Scholar
  40. 40.
    Malvaux P. Thyroid function during the neonatal period, infancy and childhood. In: Delange F., Fisher D.A., Malvaux P. (Eds.), Pediatric thyroidology. Karger, 1985, p. 33.Google Scholar
  41. 41.
    Kay C., Abrahams S., McLain P. The weight of normal thyroid glands in children. Arch. Pathol. 82: 349, 1966.PubMedGoogle Scholar
  42. 42.
    Koutras D.A., Matovinovic J., Vought R. The ecology of iodine. In: Stanbury J.B., Hetzel B.S. (Eds.) Endemic goiter and endemic cretinism. John Wiley publ., New York, 1980, p. 185.Google Scholar
  43. 43.
    Merke F. History and inconography of endemic goitre and cretinism. Hans Huber Publ., Bern, 1984, p. 1.Google Scholar
  44. 44.
    Delange F., Bastani S., Benmiloud M., DeMaeyer E., Isayama M.G., Koutras D., Muzzo S., Niepomniszcze H., Pandav C.S., Riccabona G. Definitions of endemic goiter and cretinism, classification of goiter size and severity of endemias, and survey techniques. In: Dunn J.T., Pretell E., Daza C.H., Viteri F.E. (Eds.), Towards the eradication of endemic goiter, cretinism and iodine deficiency. Pan American Health Organization Publ., Washington PAHO Sc. Publ. n∘ 502, 1986.Google Scholar
  45. 45.
    König M.P. Die Kongenitale Hypothyreose und der Endemische Kretinismus. Springer-Verlag, Berlin, 1968, p. 1.CrossRefGoogle Scholar
  46. 46.
    Delange F., Heidemann P., Bourdoux P., Larsson A., Vigneri R., Klett M., Stubbe P. Regional variations of iodine nutrition and thyroid function during the neonatal period in Europe. Biol. Neonate 49: 322, 1986.PubMedCrossRefGoogle Scholar
  47. 47.
    Report of the Subcommittee for the study of endemic goitre and iodine deficiency of the European Thyroid Association. Goitre and iodine deficiency in Europe. Lancet 1: 1289, 1985.Google Scholar
  48. 48.
    Scriba P.C. Goitre and iodine deficiency in Europe. A Review. In: Reinwein D., Scriba P.C. (Eds.), Treatment of endemic and sporadic goitre. International Thyroid Symposium. Schattauer, Stuttgart-New York, 1985, p. 19.Google Scholar
  49. 49.
    Follis R.H. Patterns of urinary iodine excretion in goitrous and non goitrous areas. Am. J. Clin. Nutr. 14: 53, 1964.Google Scholar
  50. 50.
    Bourdoux P., Thilly C., Delange F., Ermans A.M. A new look at old conceps in laboratory evaluation of endemic goiter. In: Dunn J.T., Pretell E.A., Daza C.H., Viteri F.E. (Eds.), Towards the eradication of endemic goiter, cretinism and iodine deficiency. Pan American Health Organization. WHO. Scientific publication n∘ 502, Washington, 1986, p. 115.Google Scholar
  51. 51.
    Varo P., Saari E., Paaso A., Koivistoinen P. Iodine in Finnish foods. Int. J. Vitamin. Nutr. Res. 52: 80, 1982.Google Scholar
  52. 52.
    Squatrito S., Delange F., Trimarchi F., Lisi E., Vigneri R. Endemic cretinism in Sicily. J. Endocrinol. Invest. 4: 295, 1978.CrossRefGoogle Scholar
  53. 53.
    Lagasse R., Ramioul L., Yegers O., Thilly C.H. Collaborative study of geographical variations in thyroidal uptake and iodine intake in Europe. Abstract 52. 7th Annual Meeting of the European Thyroid Association, Helsinki, 1976.Google Scholar
  54. 54.
    Bauch V.K., Weiss O., Mockel G., Gerlach J., Seitz W., Ulrich F.E., Dempe A. Der Radiojodtest zur Beurteilung des Jodmangels in Bezirk Karl-Marx-Stadt und in der DDR. Z. Gesamte Inn. Med. 19: 696, 1981.Google Scholar
  55. 55.
    Burrow G.N., Dussault J.H. Neonatal thyroid screening. Raven Press Publ., New York, 1982, p. 1.Google Scholar
  56. 56.
    Belfiore A., Sava L., Runello F., Tomaselli U., Vigneri R. Solitary autonomously functioning thyroid nodules and iodine deficiency. J. Clin. Endocrinol. Metab. 56: 283, 1983.PubMedCrossRefGoogle Scholar
  57. 57.
    Eberhard H., Eigenmann F., Schärer K., Bürgi H. Auswirkungen der verbesserten Kropfprophylaxe mit jodiertem Kochsalz auf den Jodstoffwechsel in der Schweiz. Schweiz. Med. Wschr. 113: 24, 1983.PubMedGoogle Scholar
  58. 58.
    Mornex R. Enquête sur la prévalence du goitre en France. Bull. Acad. Ntle Méd. 171: 301, 1987.Google Scholar
  59. 59.
    Meng W., Ventz M., Weber S., Bednar J. Struma und alimentärer Jodmmangel in der DDR. Dt. Gesundh. Wesen. 36: 1275, 1981.Google Scholar
  60. 60.
    Sava L., Delange F., Belfiore F., Purrello F., Vigneri R. Transient impairment of thyroid function in newborn from an area of endemic goiter. J. Clin. Endocrinol. Metab. 59: 90, 1984.PubMedCrossRefGoogle Scholar
  61. 61.
    Bauch K., Anke M., Gurtler H., Hesse V. Stromaprophylaxe in der DDR aus interdisziplinarem Sicht. Z. Gesamte Inn. Med. Jahrg. 41: 524, 1986.Google Scholar
  62. 62.
    Dunn J.T., Pretell E.A., Daza C.H., Viteri F.E. In: Dunn J.T, Pretell E.A., Daza C.H., Viteri F.E. (Eds.), Towards the eradication of endemic goiter, cretinism, and iodine deficiency. Pan American Health Organization. WHO. Scientific publication n∘ 502, Washington, 1986, p. 155.Google Scholar
  63. 63.
    Gutekunst R., Scriba P.C. Goiter and Iodine Deficiency in Europe. I.C.C.I.D.D. Newsletter 4: 1, 1988.Google Scholar
  64. 64.
    Habermann J., Heinze J., Horn K., Hanlehner R., Marschner I., Neumann I., Scriba P.C. Alimentarer Jodmangel in der Bundesrepublik Deutschland. Dtsch. Med. Woschr. 100: 1937, 1975.CrossRefGoogle Scholar
  65. 65.
    Haas V., Marley M., Green A., Date J., Blichert-Toft M., Mogensen E.F. Urinary iodine excretion in a geographically stratified Danish population sample not affected by iodination programmes. A change towards higher values. Acta Endocrinol. 11: 125, 1988.Google Scholar
  66. 66.
    Jaffiol C., Gobert M., Cailhol A., Baylet R., Baldet L., Lachiver F., Chapate M., Mirouze J. Bull. Acad. Natl. Méd. 171, 1095, 1987.PubMedGoogle Scholar
  67. 67.
    König M.P., Mordasini C., Kohler H., Lauber K. Diagnostic value of the measurement of iodine in blood and urine. In: Hall R., Kobberling. J. (Eds.), Thyroid disorders associated with iodine deficiency and excess. Serono symposia Publ., Raven Press, vol 22, 1985, p. 137.Google Scholar
  68. 68.
    Lamberg B.A. Endemic goitre in Finland and changes during 30 years of iodine prophylaxis. Endocrinol. Exp. (Bratisl.) 20, 35, 1986.Google Scholar
  69. 69.
    Stambury J.B., Brownell G.L., Riggs D.S., Perinetti H., Itoiz J., del Castillo E. The adaptation of man to iodine deficiency. In: Endemic Goiter. Harvard University Press, Cambridge, Massachusetts, 1954, p. -.CrossRefGoogle Scholar
  70. 70.
    Tubiana M., Fragu P., De Tovar G., Bazin J.P. The radioactive iodine uptake and the absolute iodine uptake in euthyroid subjects with and without sporadic goiter. In: Revue Européenne d’Etudes Cliniques et Biologiques (Flammarion) vol. 16(3), 250, 1971.Google Scholar
  71. 71.
    Vigneri R. Studies on the goiter endemia in Sicily. J. Endocrinol. Invest. 11: 831, 1988.PubMedCrossRefGoogle Scholar
  72. 72.
    Wolff J. Physiological aspects of iodine excess in relation to radiation protection. J. Mol. Med. 4: 151, 1980.Google Scholar
  73. 73.
    Linnemann R.E. Soviet medical response to the Chernobyl nuclear accident. J.A.M.A. 258: 637, 1987.PubMedCrossRefGoogle Scholar
  74. 74.
    Wenzel R.W., Lente J.R. Similar effects of thionamide drugs and Perchlorate on thyroid-stimulating immunoglobulins in Graves’ disease: evidence against an immunosuppressive action of thionamide drugs. J. Clin. Endocrinol. Metab. 58: 62, 1984.PubMedCrossRefGoogle Scholar
  75. 75.
    Martino E., Aghini-Lombardi F., Mariotti S., Lenziardi M., Baschieri L., Braverman I., Pinchera A. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of Perchlorate and methimazole. J. Endocrinol. Invest. 9: 201, 1986.PubMedCrossRefGoogle Scholar
  76. 76.
    Robbins J. Iodine deficiency, iodide excess and the use of iodine for protection against radioactive iodine. Thyroid Today 3: 1, 1980.Google Scholar
  77. 77.
    Robbins J. Indications for using potassium iodine to protect the thyroid from low level internal irradiation. Bull. N.Y. Acad. Med. 59: 1028, 1983.PubMedCentralPubMedGoogle Scholar
  78. 78.
    Wolff J. Iodine goiter and the pharmacological effects of excess iodine. Am. J. Med. 47: 101, 1969.PubMedCrossRefGoogle Scholar
  79. 79.
    Fradkin J.E., Wolff J. Iodine-induced thyrotoxicosis. Medicine 62: 1, 1983.PubMedGoogle Scholar
  80. 80.
    Ek B., Johnsson S., Von Porot B. Iodine repletion test in an endemic goiter area. Risk of iodine-induced hyperthyroidism. Acta Med. Scand. 173: 341, 1963.CrossRefGoogle Scholar
  81. 81.
    Vagenakis A.G., Wang C.A., Burger A., Maloof F., Braverman L.E., Ingbar S.H. Iodine-induced thyrotoxicosis in Boston. N. Engl. J. Med. 287: 523, 1972.PubMedCrossRefGoogle Scholar
  82. 82.
    Martins M.C., Lima N., Knobel M., Mederios-Neto G. Naturals course of iodine-induced thyrotoxicosis (Jodbasedow) in endemic goiter area: A 5 year follow up. J. Endocrinol. Invest. 12: 239, 1989.PubMedCrossRefGoogle Scholar
  83. 83.
    Unger J., Couturier E., Durez M., Dor P. Failure to reach euthyroidism with potassium iodide and propranolol in preparation of a patient with Graves’ disease for surgery. J. Endocrinol. Invest. 4: 367, 1981.PubMedCrossRefGoogle Scholar
  84. 84.
    Leger A.F., Massin J.P., Laurent M.F., Vincens M., Auriol M., Helal O.B., Chomette G., Savoie J.C. Iodine induced thyrotoxicosis: analysis of eighty five consecutive cases. Eur. J. Clin. Invest. 94: 449, 1984.CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1991

Authors and Affiliations

  • J. Malone
    • 1
  • J. Unger
    • 2
  • F. Delange
    • 3
  • R. Lagasse
    • 4
  • J. E. Dumont
    • 5
  1. 1.Department of Medical Physics and BioengineeringSt. James’s HospitalDublinIreland
  2. 2.Department of EndocrinologyErasmus HospitalRotterdamNetherland
  3. 3.Department of PediatricsHàpital Saint PierreBrusselsBelgium
  4. 4.School of Public HealthBrusselsBelgium
  5. 5.Institute of Interdisciplinary Research, School of MedicineUniversity of Brussels and Radioprotection Department, EuratomBrusselsBelgium

Personalised recommendations